Gossamer Bio advances the Feb. 2026 PROSERA Phase 3 readout for seralutinib in PAH, with expanded endpoints and a new ILD trial. Learn why GOSS stock is a hold.

BIO-Europe Startup Spotlight returns to Lisbon in March 2026, showcasing Europe’s top early-stage biotech pitches to industry leaders.

Among other book releases in 2026, with 30 short stories and 70 poems in a bilingual edition, Gulzar, the legendary poet pays ...

A comprehensive analysis of the overall social and political changes in North Korea following the development of underground ...

It's been an eventful year for the Chicago Bears. We're listing the top 15 moments of the year for the franchise.

The Laurel Denise Planner features a monthly calendar, four to five weekly short pages (so you can plan anywhere from 28 to ...

The mean of analysts' price targets for Theravance Bio (TBPH) points to a 42.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among ...

The consensus price target hints at a 25.1% upside potential for Nuvation Bio (NUVB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings ...

While working on a biography of her great-grandmother Gertrude Vanderbilt Whitney, Fiona Donovan unearthed a trove of letters ...

This week, books examined the state of our planet and included a biography of Michael Lynch and a wintry retelling of an Irish legend.

Discover why Blue Moon Beach Grill on North Carolina’s Outer Banks offers standout value with crave-worthy shrimp and grits, ...